New Partnership to Expand Access to Metagenomic Sequencing for Neurological Infections
Delve Bio partnered with Broad Clinical Labs to accelerate commercialization and accessibility of mNGS for diagnosing neurological infection.
Read MorePosted by Andy Lundin | Oct 9, 2024 | Molecular Diagnostics |
Delve Bio partnered with Broad Clinical Labs to accelerate commercialization and accessibility of mNGS for diagnosing neurological infection.
Read MorePosted by Andy Lundin | Oct 9, 2024 | Leukemia |
Researchers have developed a CRISPR-based diagnostic test that accurately detects gene fusions in APL and CML within two hours.
Read MorePosted by Andy Lundin | Oct 8, 2024 | Leukemia, Sequencing Systems |
The next-generation sequencing assay delivers rapid and comprehensive genetic profiling for AML patients, guiding precise treatment decisions.
Read MorePosted by Andy Lundin | Oct 4, 2024 | Sepsis |
Abionic’s IVD CAPSULE PSP test gained FDA 510(k) clearance to rapidly detect sepsis, marking the company’s expansion into the U.S. market.
Read MorePosted by Andy Lundin | Sep 30, 2024 | Anatomic Pathology, Cancer |
A novel pathology tool uses DNA barcoding to map RNA and proteins in tissue, offering a potential breakthrough in cancer diagnosis.
Read More